NCT07425262

A Pilot Trial of Chinese Medicine for Patients With Dialytic Hypotension

A Pilot Randomized Waitlist-controlled Trial of a Zheng-based Chinese Medicine Intervention for Patients With Dialytic Hypotension in Taiwan

• Status: Not Yet Recruiting
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Chang Gung Memorial Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the epidemiological status of traditional Chinese Medicine (TCM) constitution in patients with dialytic hypotension, and design a clinical study based on a Zheng-based herbal formulation to evaluate the clinical efficacy and safety of TCM

Conditions

• End Stage Renal Disease on Dialysis
• Intradialytic Hypotension

Interventions

Type	Name	Description
DRUG	CHM intervention group	Jia Wei Sheng Yu Si Ni Tang (JWSYSNT) powder, 4.5 gm per dose, taken orally 2 times a day, for 8 weeks
OTHER	No CHM treatment	The waitlist control group received no JWSYSNT treatments and received no other intervention for 8 weeks after randomization.

Timeline

• Start date: 2026-02-02
• Primary completion: 2028-02-01
• Completion: 2028-02-01
• First posted: 2026-02-20
• Last updated: 2026-02-25

Locations

1 site across 1 country: Taiwan